Galen E.B. Wright

2.2k citations

53 papers · 1.2k indexed · h-index 22

Impact in

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Cellular and Molecular Neuroscience top 10%
- Genetic Neurodegenerative Diseases

Papers in ⓘ

Pharmacology 16
- Pharmacogenetics and Drug Metabolism 15
Genetics 22
- Genetic Associations and Epidemiology 12
- Genomics and Rare Diseases 7

Co-authors: Britt I. Drögemöller (31 shared papers)Louise Warnich (16 shared papers)Colin J.D. Ross (18 shared papers)Michael R. Hayden (10 shared papers)Bruce Carleton (12 shared papers)Dana Niehaus (10 shared papers)Jennifer A. Collins (6 shared papers)Liezl Koen (6 shared papers)
Journals: Clinical Pharmacology & Therapeutics (6 papers)Pharmacogenomics (5 papers)Neuron (2 papers)npj Genomic Medicine (2 papers)Pharmacogenetics and Genomics (2 papers)
Partner nations: Canada South Africa United States

In The Last Decade

Galen E.B. Wright

53 papers receiving 1.2k citations

Peers

Countries citing papers authored by Galen E.B. Wright

Since Specialization

Citations

This map shows the geographic impact of Galen E.B. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galen E.B. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galen E.B. Wright more than expected).

Fields of papers citing papers by Galen E.B. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galen E.B. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galen E.B. Wright. The network helps show where Galen E.B. Wright may publish in the future.

Co-authors

The 25 scholars most cited alongside Galen E.B. Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Galen E.B. Wright Line = papers co-authored together Galen E.B. Wright links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Length of Uninterrupted CAG, Independent of Polyglutamine Size, Results in Increased Somatic Instability, Hastening Onset of Huntington Disease The American Journal of Human Genetics ·Galen E.B. Wright, Jennifer A. Collins, Chris Kay, Cassandra McDonald, Egor Dolzhenko, Qingwen Xia, Kristina Bečanović, Britt I. Drögemöller, Alicia Semaka, Charlotte Nguyen, Brett Trost, Fiona Richards, Emilia K. Bijlsma, Ferdinando Squitieri, Colin J.D. Ross, Stephen W. Scherer, Michael A. Eberle, Ryan K. C. Yuen, Michael R. Hayden	2019	120
2	The global spectrum of protein-coding pharmacogenomic diversity The Pharmacogenomics Journal ·Galen E.B. Wright, Bruce Carleton, Michael R. Hayden, Colin J.D. Ross	2016	67
3	Nuclear Receptor NR1H3 in Familial Multiple Sclerosis Neuron ·Zhe Wang, A. Dessa Sadovnick, Anthony Traboulsee, Jay P. Ross, Cecily Q. Bernales, Mary Joy Encarnacion, Irene M. Yee, Madonna de Lemos, Talitha Greenwood, Joshua D. Lee, Galen E.B. Wright, Colin J.D. Ross, Si Zhang, Weihong Song, Carles Vilariño‐Güell	2016	65
4	Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation Current pharmacogenomics and personalized medicine (Online) ·Louise Warnich, Britt I. Drögemöller, Michael S. Pepper, Collet Dandara, Galen E.B. Wright	2011	55
5	The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Chris Kay, Jennifer A. Collins, Galen E.B. Wright, Fiona Baine, Zosia Miedzybrodzka, Folefac Aminkeng, Alicia Semaka, Cassandra McDonald, M. J. Davidson, Steven J. Madore, Erynn S. Gordon, Norman P. Gerry, Mario Cornejo‐Olivas, Ferdinando Squitieri, Sarah A. Tishkoff, Jacquie Greenberg, Amanda Krause, Michael R. Hayden	2018	55
6	Pharmacogenomics of Vincristine‐Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes Clinical Pharmacology & Therapeutics ·Galen E.B. Wright, Ursula Amstutz, Britt I. Drögemöller, Joanne Shih, Shahrad R. Rassekh, Michael R. Hayden, Bruce Carleton, Colin J.D. Ross	2018	49
7	Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies The Lancet Neurology ·Galen E.B. Wright, Hailey Findlay Black, Jennifer A. Collins, Terence Gall-Duncan, Nicholas S. Caron, Christopher E. Pearson, Michael R. Hayden	2020	47
8	Elucidation of CYP2D6 Genetic Diversity in a Unique African Population: Implications for the Future Application of Pharmacogenetics in the Xhosa Population Annals of Human Genetics ·Galen E.B. Wright, Dana Niehaus, Britt I. Drögemöller, Liezl Koen, Andrea Gaedigk, Louise Warnich	2010	46
9	Ethical and legal implications of whole genome and whole exome sequencing in African populations BMC Medical Ethics ·Galen E.B. Wright, Pieter Koornhof, Adebowale Adeyemo, Nicki Tiffin	2013	45
10	Characterization of the Genetic Profile of CYP2C19 in Two South African Populations Pharmacogenomics ·Britt I. Drögemöller, Galen E.B. Wright, Dana Niehaus, Liezl Koen, Stefanie Malan‐Müller, Danielle M Da Silva, Renate Hillermann–Rebello, Anthony M La Grange, Mauritz Venter, Louise Warnich	2010	44
11	Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study BMC Medical Genetics ·Tyren M. Dodgen, Warren E. Hochfeld, Heidi Fickl, Sahle M. Asfaha, Chrisna Durandt, Paul Rheeder, Britt I. Drögemöller, Galen E.B. Wright, Louise Warnich, Christiaan DJ Labuschagne, Antoinette van Schalkwyk, Andrea Gaedigk, Michael S. Pepper	2013	42
12	StellarPGx: A Nextflow Pipeline for Calling Star Alleles in Cytochrome P450 Genes Clinical Pharmacology & Therapeutics ·David Twesigomwe, Britt I. Drögemöller, Galen E.B. Wright, Azra Siddiqui, Jorge da Rocha, Zané Lombard, Scott Hazelhurst	2021	41
13	Characterization of the genetic variation present in CYP3A4 in three South African populations Frontiers in Genetics ·Britt I. Drögemöller, Marieth Plummer, Lundi Korkie, Gloudi Agenbag, Anke Dunaiski, Dana Niehaus, Liezl Koen, G. Gebhardt, Nicol Schneider, Antonel Olckers, Galen E.B. Wright, Louise Warnich	2013	40
14	A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping npj Genomic Medicine ·David Twesigomwe, Galen E.B. Wright, Britt I. Drögemöller, Jorge da Rocha, Zané Lombard, Scott Hazelhurst	2020	38
15	A Systematic Review and Analysis of the Use of Polygenic Scores in Pharmacogenomics Clinical Pharmacology & Therapeutics ·Danielle Johnson, MacKenzie A.P. Wilke, Sarah M. Lyle, Kaarina Kowalec, Andrea Jorgensen, Galen E.B. Wright, Britt I. Drögemöller	2021	33
16	Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range Genetics in Medicine ·Hailey Findlay Black, Galen E.B. Wright, Jennifer A. Collins, Nicholas S. Caron, Chris Kay, Qingwen Xia, Larissa Arning, Emilia K. Bijlsma, Ferdinando Squitieri, Huu Phuc Nguyen, Michael R. Hayden	2020	32
17	Next-generation sequencing of pharmacogenes Pharmacogenetics and Genomics ·Britt I. Drögemöller, Galen E.B. Wright, Dana Niehaus, Robin Emsley, Louise Warnich	2013	29
18	Further Investigation of the Role of ACYP2 and WFS1 Pharmacogenomic Variants in the Development of Cisplatin-Induced Ototoxicity in Testicular Cancer Patients Clinical Cancer Research ·Britt I. Drögemöller, Beth Brooks, Carol Critchley, Jose Gerard Monzon, Galen E.B. Wright, Geoffrey Liu, Daniel J. Renouf, Christian Kollmannsberger, Philippe L. Bédard, Michael R. Hayden, Karen A. Gelmon, Bruce Carleton, Colin J.D. Ross	2018	28
19	Bupropion in the long-term treatment of cyclic mood disorders: mood stabilizing effects. PubMed ·Galen E.B. Wright, Lindsay Galloway, J Kim, Margarida Dalton, Laurie A. Miller, William Stern	1985	28
20	Sequencing of GJB2 in Cameroonians and Black South Africans and comparison to 1000 Genomes Project Data Support Need to Revise Strategy for Discovery of Nonsyndromic Deafness Genes in Africans OMICS A Journal of Integrative Biology ·Jason Bosch, Jean Jacques Noubiap, Collet Dandara, Nomlindo Makubalo, Galen E.B. Wright, Jean-Baka Domelevo Entfellner, Nicki Tiffin, Ambroise Wonkam	2014	24

About Galen E.B. Wright

Galen E.B. Wright is a scholar working on Pharmacology, Genetics, Cellular and Molecular Neuroscience, Oncology and Virology, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (15 papers), Genetic Associations and Epidemiology (12 papers), Genetic Neurodegenerative Diseases (9 papers), Genomics and Rare Diseases (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Schizophrenia research and treatment (5 papers), Mitochondrial Function and Pathology (4 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Pharmacology (402 citations), Cellular and Molecular Neuroscience (265 citations), Genetics (320 citations), Sensory Systems (48 citations) and Neurology (132 citations). Galen E.B. Wright has collaborated with scholars based in Canada, South Africa and United States. Frequent co-authors include Britt I. Drögemöller, Louise Warnich, Colin J.D. Ross, Michael R. Hayden, Bruce Carleton, Dana Niehaus, Jennifer A. Collins, Liezl Koen, Michael S. Pepper and Nicki Tiffin. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Pharmacogenomics, Neuron, npj Genomic Medicine and Pharmacogenetics and Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact